Asthma is an inflammatory disease of the airways. Acute exacerbations occur as part of the natural history of the disease due to airways irritants and treatment failure [1] [2] [3] [4] . A substantial proportion of direct asthma costs result from the cost of treating acute asthma exacerbations [1] . Acute asthma is one of the most frequent reasons for attendance at the Emergency Department (ED) [3] [4] . Despite international guidelines recommending appropriate therapy for acute asthma attacks, they are often poorly managed [1] . For practical purposes, an acute exacerbation can be generally defined as an acute or subacute episodes of progressively worsening shortness of breath, cough, wheezing, and chest tightness or some combination of these symptoms [1] . Exacerbations are characterized by decreases in expiratory airflow that can be documented and quantified by simple measurement of lung function (forced expiratory volume in 1 second [FEV1] or peak expiratory flow rate [PEFR] ). The severity of asthma exacerbations ranges from mild to life-threatening. Early treatment of asthma exacerbations is the best strategy for management. Initial assessment should include a brief history, brief physical examination, and, for most patients, objective measures of lung function. FEV1 or PEFR to provide important information about the level of airflow obstruction both initially (Table I ) and in response to treatment (Table II Table I . Classifying severity of asthma exacerbations [4] short acting beta-2 agonist (SABA) and, early in the course of treatment, administration of corticosteroids (CS) to patients who have moderate or severe exacerbations or to patients who fail to respond promptly and completely to SABA treatment; 3. Reduction of the likelihood of relapse of the exacerbation or future recurrence of severe airflow obstruction by intensifying therapy. The response to initial treatment in the ED is a better predictor of the need for hospitalization than is the severity of an exacerbation on presentation.
